top of page

ALKemist Bio
Next generation cell therapies for ALK-positive cancer patients

Our Vision 


We aim to offer a cell therapy approach to target ALK-positive cancer cells, responsible for the acquisition of resistance and low progression-free survival of ALK-positive patients.


ALK positive tumors

ALK-positive (ALK+) cancer is mainly present in patients in the form of non-small cell lung cancer, but it can also originate in many other parts of the body, including the brain and breast.

ALK oncogene

Anaplastic lymphoma kinase (ALK) was originally discovered in 1994, in anaplastic large-cell lymphoma cells. An oncogene is a gene that is a mutated and is the main driver of cancer cells. 

bottom of page